-
Dec 4, 2024 | 00381-0/fulltext?rss=yes&sz=64)
resmedjournal.com | UCL Respiratory |Michael Tunney |Zina Alfahl |Gisli G Einarsson |J. Stuart Elborn |Deirdre F Gilpin | +10 more
KeywordsBronchiectasismicrobiome compositionquantitative real time PCRbacterial densityclinical outcomesquality of lifeGet full text accessLog in, subscribe or purchase for full access. REFERENCES1. O’Donnell, A.E.Bronchiectasis updateCurrent Opinion in Infectious Diseases. 2018; 312. Chandrasekaran, R. ∙ Mac Aogáin, M. ∙ Chalmers, J.D. ... Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasisBMC Pulmonary Medicine. 2018; 18:833. Chalmers, J.D. ∙ Polverino, E.
-
Jul 1, 2024 | 
openres.ersjournals.com | John R. Hurst |Carlos Echevarria |Jennifer K Quint |Samantha Walker
IntroductionEarly in the COVID-19 pandemic, the prevalence of asthma and COPD in hospitalised patients with COVID-19 was low, raising the possibility that pre-existing airway diseases or inhaled corticosteroid (ICS) therapy might play a protective role against contracting SARS-CoV-2 infection or severe outcomes [1, 2].
-
Apr 4, 2024 | 
erj.ersjournals.com | John R. Hurst
FootnotesConflict of interest: A. Aboelhassan has no potential conflicts of interest to disclose. J.R. Hurst reports grants, travel support and advisory board participation from AstraZeneca, consulting fees from AstraZeneca and GSK, lecture honoraria from AstraZeneca, Boehringer Ingelheim, Chiesi, Sanofi and Takeda, and donation of oximeters from Nonin, outside the submitted work. Received February 20, 2024. Accepted March 10, 2024.
-
Mar 1, 2024 | 00038-9/abstract?rss=yes&sz=64)
thelancet.com | John R. Hurst |UCL Respiratory |Chris Gale
Chronic obstructive pulmonary disease (COPD) and cardiovascular disease are both major global public health burdens, with a burden of 74·4 million and 393 million disability-adjusted life-years, respectively, in 2019.Given shared exposures and risk factors (eg, smoking, socioeconomic deprivation, diabetes, hypertension, low levels of exercise, and dyslipidaemia), it is not surprising that many people living with COPD have cardiovascular disease.
-
Jan 1, 2024 | 
openres.ersjournals.com | Bill King |Andrew Cumella |Nicholas S Hopkinson |John R. Hurst
IntroductionChronic lung diseases are a leading cause of morbidity and mortality worldwide [1]. A key contributor to the burden of chronic lung disease at a patient and health system level is acute exacerbations of respiratory symptoms. These exacerbations are commonly caused by respiratory viral infections [2]. Severe exacerbations that result in hospitalisation are costly and often make up a large majority of the treatment costs of chronic lung disease [3–6].
-
Nov 1, 2023 | 
openres.ersjournals.com | UCL Respiratory |John R. Hurst
To the Editor:Respiratory diseases such as asthma, COPD and coronavirus disease 2019 (COVID-19) are a significant global health concern. A large volume of original research is generated, which has the most potential for impact when disseminated widely. Traditional bibliometrics such as citations and impact factor (IF) of the publishing journal do not capture online dissemination of information, including through social media.
-
Oct 24, 2023 | 
emjreviews.com | John R. Hurst |Helen Reddel |Christine Jenkins |Ekaterina Maslova
Introduction John Hurst Hurst set the scene by highlighting that policymakers face significant challenges in addressing the post-COVID-19 priorities of resolving health inequity, building system resilience, and reducing greenhouse gas (GHG) emissions.1 Improvements in respiratory care have stalled in recent years.2 He noted that this slow-down has not occurred universally amongst all patients living with respiratory disease; rather, a disproportionate burden of mortality and morbidity due to...
-
Sep 28, 2023 | 
openres.ersjournals.com | UCL Respiratory |John R. Hurst
FootnotesThis manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article. Conflict of Interest: The authors have nothing to disclose. This is a PDF-only article.
-
May 16, 2023 | 
thorax.bmj.com | Chidiamara Maria Njoku |John R. Hurst |Leigh Kinsman |Saliu Balogun
http://orcid.org/0000-0003-3758-2422Chidiamara Maria Njoku1, http://orcid.org/0000-0002-7246-6040John R Hurst2, Leigh Kinsman3, Saliu Balogun4, Kehinde Obamiro5 1 College of Health Sciences, Sport and Exercise Science, James Cook University Division of Tropical Health and Medicine, Townsville, Queensland, Australia 2 Academic Unit of Respiratory Medicine, UCL Medical School, London, UK 3 School of Nursing and Midwifery, The University of Newcastle School of Nursing and Midwifery, Callaghan,...
-
May 10, 2023 | 
dialnet.unirioja.es | Marc Miratvilles |John R. Hurst
Optimal Treatment of the Symptomatic Smoker:: Make a Diagnosis Not Empiric TreatmentMarc Miravitlles[1];John R.
